Date published: 2025-11-1

1-800-457-3801

SCBT Portrait Logo
Seach Input

[D-Arg1,D-Phe5,D-Trp7,9,Leu11]-Substance P (CAS 96736-12-8)

0.0(0)
Write a reviewAsk a question

See product citations (1)

Application:
[D-Arg1,D-Phe5,D-Trp7,9,Leu11]-Substance P is a broad spectrum neuropeptide antagonist and inverse agonist
CAS Number:
96736-12-8
Molecular Weight:
1516.85
Molecular Formula:
C79H109N19O12
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.
* Refer to Certificate of Analysis for lot specific data.

QUICK LINKS

[D-Arg1,D-Phe5,D-Trp7,9,Leu11]-Substance P has been shown to be a broad spectrum neuropeptide antagonist and inverse agonist. This compound has also been reported to be a potent full inverse agonist for the ghrelin receptor. Additional research has proven that this compound induces apoptosis and is also an antagonist at tachykinin, bradykinin, CCK and bombesin receptors.


[D-Arg,[object Object],,D-Phe,[object Object],,D-Trp,[object Object],,Leu,[object Object],]-Substance P (CAS 96736-12-8) References

  1. Bcl-2-independent induction of apoptosis by neuropeptide receptor antagonist in human small cell lung carcinoma cells.  |  Matsumoto, Y., et al. 2000. Anticancer Res. 20: 3123-9. PMID: 11062732
  2. High constitutive signaling of the ghrelin receptor--identification of a potent inverse agonist.  |  Holst, B., et al. 2003. Mol Endocrinol. 17: 2201-10. PMID: 12907757
  3. In vitro effects of substance P analogue [D-Arg1, D-Phe5, D-Trp7,9, Leu11] substance P on human tumour and normal cell growth.  |  Everard, MJ., et al. 1992. Br J Cancer. 65: 388-92. PMID: 1373071
  4. [D-Arg1,D-Phe5,D-Trp7,9,Leu11]substance P, a neuropeptide antagonist, blocks binding, Ca2(+)-mobilizing, and mitogenic effects of endothelin and vasoactive intestinal contractor in mouse 3T3 cells.  |  Fabregat, I. and Rozengurt, E. 1990. J Cell Physiol. 145: 88-94. PMID: 1698796
  5. Ghrelin decreases microvascular leak during inflammation.  |  Kwan, RO., et al. 2010. J Trauma. 68: 1186-91. PMID: 20068486
  6. [D-Arg1,D-Phe5,D-Trp7,9,Leu11]substance P, a potent bombesin antagonist in murine Swiss 3T3 cells, inhibits the growth of human small cell lung cancer cells in vitro.  |  Woll, PJ. and Rozengurt, E. 1988. Proc Natl Acad Sci U S A. 85: 1859-63. PMID: 2450349
  7. [D-Arg1, D-Phe5, D-Trp7,9, Leu11] substance P induces apoptosis in lung cancer cell lines in vitro.  |  Reeve, JG. and Bleehen, NM. 1994. Biochem Biophys Res Commun. 199: 1313-9. PMID: 7511895
  8. Stability and in vitro metabolism of the mitogenic neuropeptide antagonists [D-Arg1,D-Phe5, D-Trp7,9, Leu11]-substance P and [Arg6, D-Trp7,9, MePhe8]-substance P (6-11) characterized by high-performance liquid chromatography.  |  Cummings, J., et al. 1994. J Pharm Biomed Anal. 12: 811-9. PMID: 7522585
  9. Differential modulation of bombesin-stimulated phospholipase C beta and mitogen-activated protein kinase activity by [D-Arg1,D-Phe5,D-Trp7,9,Leu11]substance P.  |  Mitchell, FM., et al. 1995. J Biol Chem. 270: 8623-8. PMID: 7536738
  10. [D-Arg1, D-Phe5, D-Trp7,9, Leu11] substance P inhibits the growth of human small cell lung cancer xenografts in vivo.  |  Everard, MJ., et al. 1993. Eur J Cancer. 29A: 1450-3. PMID: 7691115
  11. [D-Arg1,D-Trp5,7,9,Leu11]Substance P coordinately and reversibly inhibits bombesin- and vasopressin-induced signal transduction pathways in Swiss 3T3 cells.  |  Seckl, MJ., et al. 1996. J Biol Chem. 271: 29453-60. PMID: 8910612
  12. Processing of [D-Arg1,D-Phe5,D-Trp7,9,Leu11]substance P in xenograft bearing Nu/Nu mice.  |  Jones, DA., et al. 1997. Peptides. 18: 1073-7. PMID: 9357069
  13. [D-Arg1,D-Phe5,D-Trp7,9,Leu11]Substance P acts as a biased agonist toward neuropeptide and chemokine receptors.  |  Jarpe, MB., et al. 1998. J Biol Chem. 273: 3097-104. PMID: 9446627

Ordering Information

Product NameCatalog #UNITPriceQtyFAVORITES

[D-Arg1,D-Phe5,D-Trp7,9,Leu11]-Substance P, 1 mg

sc-361166
1 mg
$94.00